Terpenes Vs Cannabinoids : What Is The Difference?

Walk into any cannabis lab and you'll hear "terpenes" and "cannabinoids" used in the same breath, as if they're two flavours of the same thing. They aren't. Cannabinoids bind directly to receptors in the human endocannabinoid system. Most terpenes don't. There is one famous exception, beta-caryophyllene, and it matters more than the rest combined. Everything else, the aroma, the "indica vs sativa" mood story, the entourage effect, hangs off that one chemistry distinction.

This guide is written for product developers, formulators and brand owners who need to talk about these two compound families without getting it wrong on a label, a deck, or a regulator's call. It's reviewed by Dr. Jeff Raber, Ph.D., organic chemist, founder of The Werc Shop, and holder of nine US patents in terpene formulation. We'll keep the chemistry tight and the implications practical.

What Are Cannabinoids?

Cannabinoids are a family of oxygen-containing compounds chemists classify as meroterpenoids, meaning they're built from a terpene backbone fused with a phenolic ring. They are biosynthesised almost exclusively in cannabis (and, in tiny amounts, a handful of unrelated plants and animals). The two everyone knows are delta-9-tetrahydrocannabinol (THC, PubChem CID 16078, molecular formula C₂₁H₃₀O₂) and cannabidiol (CBD, PubChem CID 644019, same formula but a different ring structure).

What makes cannabinoids pharmacologically distinct is that they bind directly to the human endocannabinoid system. There are two main receptors. CB1 sits mostly in the central nervous system, in the brain regions that handle mood, memory, appetite and pain perception. CB2 sits mostly in the immune system and peripheral tissues, which is why its activation tends to read as anti-inflammatory rather than psychoactive.

THC is the psychoactive one because it's a partial agonist at CB1. CBD is not psychoactive because it has very low affinity for CB1 and works through a more complicated set of indirect mechanisms, including modulating how the body processes its own endocannabinoids. Same molecular formula, different ring closure, completely different feel.

What Are Terpenes?

Terpenes are a much older, much broader chemical family. They're built from five-carbon isoprene units (C₅H₈) stacked together. Two isoprenes give a monoterpene (C₁₀H₁₆, the size of myrcene and limonene), three give a sesquiterpene (C₁₅H₂₄, the size of beta-caryophyllene), and so on. Around 30,000 terpenes have been catalogued across the plant kingdom. Pine resin, citrus peel, lavender, hops, black pepper, mango, all running on terpenes.

In cannabis, terpenes are produced in the same glandular trichomes that produce cannabinoids, which is part of the reason the two were lumped together for so long. But chemically they're hydrocarbons (mostly no oxygen, no nitrogen), they're volatile (they evaporate at relatively low temperatures), and they're what your nose picks up the moment you crack a jar. Strain personality, citrus, pine, gas, cherry, that's terpenes doing the talking.

For a deeper look at the terpene side specifically, our complete guide to terpenes goes through each of the major cannabis terpenes in detail.

The Key Differences Between Terpenes And Cannabinoids

Here's the side-by-side most brand decks miss. We've kept the cells short on purpose, so a label-review team can scan it in 30 seconds.

Property	Cannabinoids	Terpenes
Chemical class	Meroterpenoids (oxygen-containing)	Hydrocarbons built from isoprene units
Where they're made in cannabis	Glandular trichomes	Glandular trichomes
Found outside cannabis?	Almost exclusively cannabis	Roughly 30,000 known, across most plants
Receptor binding	Direct agonists at CB1 and/or CB2	Mostly no direct CB1/CB2 binding (one exception, see below)
Psychoactive?	THC yes, CBD no, others vary	Generally no
Responsible for aroma?	No (cannabinoids are largely odourless)	Yes, entirely
Typical boiling point	THC ~157°C, CBD ~160-180°C	Myrcene ~167°C, limonene ~176°C, β-caryophyllene ~262°C
Regulatory status (US federal)	THC Schedule I, CBD complicated	Most are food-grade GRAS

The single most important row in that table is "receptor binding". It's the one that decides how a regulator, a clinician and a consumer should think about each compound. Cannabinoids work on you through the endocannabinoid system. Terpenes mostly do not, with the one exception we're about to explain.

If you want to go deeper on how individual terpenes behave at the strain level, see our breakdown of cannabis terpene profiles and the common terpenes in cannabis.

The Exception That Proves The Rule: Beta-Caryophyllene

If you only remember one piece of cannabis chemistry, make it this. In 2008, Jürg Gertsch and colleagues at ETH Zürich and the University of Bonn published a paper in the Proceedings of the National Academy of Sciences titled, plainly, "Beta-caryophyllene is a dietary cannabinoid." They showed that this single sesquiterpene, the same compound that gives black pepper its bite, selectively binds the CB2 receptor with a Ki of 155 ± 4 nM. That's tight, real binding, not handwaving.

They went further. They showed that oral beta-caryophyllene (BCP) reduced inflammatory response in wild-type mice but had no effect in mice genetically lacking the CB2 receptor. That's the textbook design for proving a mechanism. It's not "BCP correlates with anti-inflammatory effects." It's "BCP acts through CB2 specifically."

This is why we treat BCP as a category of one. It blurs the line between terpene and cannabinoid. It's the only common cannabis terpene with confirmed, selective, direct activity at a cannabinoid receptor. For the product implications, see our deep dive on beta-caryophyllene effects and the caryophyllene effects in cannabis piece.

The Entourage Effect: What The Science Actually Says

The "entourage effect" is the idea that whole-plant cannabis is more than the sum of its parts, that terpenes and minor cannabinoids modulate how THC and CBD feel. It got its modern formulation from Ethan Russo's 2011 paper in the British Journal of Pharmacology, "Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects." Russo proposed that limonene, myrcene, pinene, linalool and other terpenes could synergise with cannabinoids to treat pain, inflammation, anxiety and more.

It's an attractive hypothesis. It's also still being argued out. Here's the honest state of play.

Evidence in favour: LaVigne et al., 2021, Scientific Reports ("Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity"). They tested alpha-humulene, geraniol, linalool and beta-pinene in mice and found these terpenes produced classic cannabinoid tetrad behaviours (reduced movement, reduced body temperature, pain relief, catalepsy). In vitro, they reported the terpenes activated CB1. They also found the behavioural effects were additive with the cannabinoid agonist WIN55,212. That's the strongest pro-entourage evidence we have for terpenes acting through cannabinoid receptors beyond BCP.

Evidence against: Finlay and colleagues published in Frontiers in Pharmacology in 2020 with the blunter title "Terpenoids from cannabis do not mediate an entourage effect by acting at cannabinoid receptors." They tested myrcene, alpha-pinene, beta-pinene, beta-caryophyllene and limonene and found no direct CB1 binding, no modulation of THC or CBD binding, and no functional effects at the receptor, with the partial exception of a weak beta-caryophyllene interaction at CB2. Santiago et al. (2019) reached a similar null conclusion.

So which is right? Probably both, in a way that's less satisfying than a clean answer. The LaVigne work suggests terpenes may produce cannabis-like behavioural effects through a mix of receptors. The Finlay work suggests that whatever terpenes are doing, the simple "they bind CB1 like THC does" story doesn't hold up at standard receptor assays. Hanuš and Hod (2020) in Medical Cannabis and Cannabinoids put it pragmatically: terpenes appear to do something in combination with cannabinoids, but beta-caryophyllene is the only one with a confirmed direct ECS mechanism.

If a marketing team comes to you wanting to claim the entourage effect on a label, the responsible answer is: there's preclinical evidence for synergy, but the mechanism isn't settled, and the cleanest path is to talk about chemovars (terpene-plus-cannabinoid profiles) rather than mechanistic promises.

Why This Matters For Product Formulation

The terpene-versus-cannabinoid distinction isn't an academic curiosity. It changes how you build a product, how you label it, and how you sell it across jurisdictions.

Cannabinoid-dominant products (vape carts with high THC, RSO, distillate edibles) sell on potency. They sit firmly inside cannabis regulation, they require licensed retail, and they're priced largely on milligrams of cannabinoid. Their experience profile is shaped by the cannabinoid load first, with terpenes added back for flavour and to nudge mood.

Terpene-dominant products (pre-roll infusions, vape blends formulated for a strain profile, aromatherapy-adjacent skus) sell on experience and authenticity. Most terpenes are GRAS food-grade ingredients, which means they can move through wider channels than scheduled cannabinoids, and they're priced on flavour-fidelity and source rather than milligrams. A well-built terpene blend can take a flat distillate cart and give it back the personality the original flower had.

Full-spectrum products try to keep both. They're harder to make consistent, more expensive to formulate, and they're where the entourage hypothesis matters most commercially. If you sell the "whole plant" story, you have to keep terpene ratios stable from batch to batch, which is why most full-spectrum operators end up reintroducing standardised terpene fractions to compensate for what extraction strips out. Our cannabis-derived terpenes guide goes into that production reality in more depth.

At Entour, we build across all three positions. Native® Blends are cultivar-specific botanical formulations. Inspired Blends push into unique flavour territory. Live Derived® Blends are the highest-fidelity option for brands that want true-to-plant chemistry. And our Effects Blends are formulated around target outcomes (activate, sedate, elevate) rather than strain provenance.

Frequently Asked Questions

Are terpenes psychoactive?

In the THC sense, no. Most terpenes don't bind CB1 directly and won't get you high. They can shape mood and arousal (linalool reads as calming, limonene as uplifting, alpha-pinene as alerting), but that's a different mechanism from the cannabinoid high.

Do terpenes get you high?

No, with the caveat that beta-caryophyllene activates CB2 (the immune-side cannabinoid receptor) and may contribute to anti-inflammatory effects. CB2 activation is not what produces the THC high, which is a CB1 event in the central nervous system.

What is the difference between terpenes and THC?

THC is a cannabinoid, an oxygen-containing meroterpenoid that binds CB1 in the brain and produces psychoactive effects. Terpenes are aromatic hydrocarbons that mostly don't bind cannabinoid receptors and don't produce a high. THC is found almost exclusively in cannabis; terpenes are found across the plant kingdom.

Can you have terpenes without cannabinoids?

Yes. Botanical terpene blends used in flavouring, cosmetics and food contain zero cannabinoids. This is one of the main reasons terpene-dominant products can move through wider commercial channels than THC products.

Are terpenes safer than cannabinoids?

"Safer" depends on use. Most cannabis terpenes are GRAS food-grade compounds in the doses typical of finished products. THC has well-known acute effects (impairment, anxiety at high doses) that pure terpene blends do not produce. But terpenes are not inert: concentrated terpenes are skin and respiratory irritants and shouldn't be used neat. Both compound families need proper dosing.

Do terpenes show up on drug tests?

No. Drug tests look for THC metabolites (specifically THC-COOH). Terpenes share no structural similarity with THC and aren't detected by the standard immunoassays or confirmatory GC-MS panels used in workplace testing.

Building Products That Use This Distinction Properly

If you've made it this far, you already know the practical takeaway. Cannabinoids and terpenes are two different families of molecules that happen to share a trichome. Treat them as different ingredients. Source them differently. Label them differently. Talk to your customers about them differently.

At Entour, we've spent over a decade formulating terpene blends for cannabis brands at every scale. If you're sitting on a chemovar story, a full-spectrum SKU, or an effects-led product line and you want it built on real chemistry rather than marketing copy, we can help. Start with a sample pack if you want to taste the difference before committing, or talk to us directly about a custom formulation.

Continue reading from our terpene guides

If you want to go deeper on the practical and commercial side of terpenes, these are the guides we update most often in the Entour library.

• Best terpene company for cannabis brands in 2026. How to evaluate a B2B terpene supplier on chemistry, transparency, and consistency.
• B2B guide: how to source wholesale terpenes. Practical sourcing playbook for brands, formulators, and procurement teams.
• Terpene calculator: how much terpene per ounce. Working math for dosing concentrates, edibles, and vape formulations.
• Terpenes in edibles and beverages: a formulator's guide. Format-specific considerations for ingestible products.
• The art of terpene combinations: creating custom blends. How experienced formulators stack terpenes for target profiles.
• The high-stakes world of online terpene shopping. What to verify before paying any online terpene vendor.
• Top terpene trends in 2026. Where formulation, regulation, and consumer demand are heading next.
• What is the terpene that causes psychedelic effects?. A look at the science behind reported psychedelic-leaning terpene profiles.

Browse Entour's terpene catalogue

Looking at specific product formats? Jump straight to Live Terpenes · Native® blends · Inspired® blends · Live Derived® blends · Effects blends · Single terpene isolates · Sample packs.